TCL Archive With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting. June 13, 2008
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center. September 15, 2006
TCL Archive President’s FY 1988 Budget Request For NCI: $1.87 Billion, But It Really Isn’t What It Seems To Be January 9, 1987
